Related references
Note: Only part of the references are listed.Alpha-lipoic acid attenuates cisplatin-induced acute kidney injury in mice by suppressing renal inflammation
Kyung Pyo Kang et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care
Vincent Launay-Vacher et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy
Yong Lin et al.
CURRENT CANCER DRUG TARGETS (2008)
Regulation and Pathological Role of p53 in Cisplatin Nephrotoxicity
Man Jiang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Genistein protects the kidney from cisplatin-induced injury
Mi Jeong Sung et al.
KIDNEY INTERNATIONAL (2008)
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
N. Pabla et al.
KIDNEY INTERNATIONAL (2008)
Anti-Oxidant, Anti-inflammatory and Anti-Allergic Activities of Luteolin
Guenter Seelinger et al.
PLANTA MEDICA (2008)
How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?
Jerry E. Chipuk et al.
TRENDS IN CELL BIOLOGY (2008)
Activation and involvement of p53 in cisplatin-induced nephrotoxicity
Qingqing Wei et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Sensitizing HER2-overexpressing cancer cells to luteolin-induced apoptosis through suppressing p21WAF1/CLP1 expression with rapamycin
Chun-Te Chiang et al.
MOLECULAR CANCER THERAPEUTICS (2007)
A critical role of luteolin-induced reactive oxygen species in blockage of tumor necrosis factor-activated nuclear factor-κB pathway and sensitization of apoptosis in lung cancer cells
Wei Ju et al.
MOLECULAR PHARMACOLOGY (2007)
Effects of hydroxyl radical. scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity
Man Jiang et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Luteolin sensitizes the anticancer effect of cisplatin via c-Jun NH2-terminal kinase-mediated p53 phosphorylation and stabilization
Ranxin Shi et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Evaluation of the anti-inflammatory activity of luteolin in experimental animal models
Li Ziyan et al.
PLANTA MEDICA (2007)
Biochemical Mechanisms of Cisplatin Cytotoxicity
Victoria Cepeda et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2007)
Protective role of L-2-oxothiazolidine-4-carboxylic acid in cisplatin-induced renal injury
Sik Lee et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Regulation of PUMA-α by p53 in cisplatin-induced renal cell apoptosis
M. Jiang et al.
ONCOGENE (2006)
A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity
Manchang Liu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Dissecting p53-dependent apoptosis
J. E. Chipuk et al.
CELL DEATH AND DIFFERENTIATION (2006)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis
JE Chipuk et al.
SCIENCE (2004)
Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis
JJA Hendricks et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Luteolin sensitizes tumor necrosis factor-α-induced apoptosis in human tumor cells
RX Shi et al.
ONCOGENE (2004)
Luteolin as an anti-inflammatory and anti-allergic constituent of Perilla frutescens
H Ueda et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2002)
TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity
G Ramesh et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Cisplatin-induced renal cell apoptosis: Caspase 3-dependent and -independent pathways
BS Cummings et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Share Paper
